(Circulation. 1999;100:1555-1561.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From the Department of Physiology, Medical College of Wisconsin, Milwaukee.
Correspondence to David W. Stepp, PhD, Department of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226. E-mail dstepp{at}post.its.mcw.edu
| Abstract |
|---|
|
|
|---|
increased
shear
vasodilation
decreased velocity
shear normalized).
Therefore, we hypothesized that shear stress would be at least
partially regulated during conditions of elevated flow. Methods and ResultsWe used fluorescence microangiography to measure microvascular diameters and velocities in the coronary circulation in vivo and used these variables to calculate shear stress. Measurements were obtained under basal conditions, during maximal coronary blood flow, and after inhibition of NO synthase. Basal shear stress in the coronary circulation averaged 10 dyn/cm2 in small arteries and 19 dyn/cm2 in arterioles. Regulation of shear stress was observed in small arteries during adenosine-induced increases in coronary blood flow, but arterioles showed minimal regulation. NO synthase blockade had no effect on basal shear stress but completely abolished its regulation in small arteries during vasodilation.
ConclusionsOur data provide the first quantitative estimates of microvascular shear stress in the coronary circulation. Moreover, our results suggest that shear stress in small coronary arteries is regulated by NO release from the endothelium.
Key Words: stress circulation nitric oxide synthase
| Introduction |
|---|
|
|
|---|
Flow-mediated dilation is induced by changes in shear stress.4 An increase in microvascular flow velocity produces increased shear stress when viscosity and diameter are constant. The increased shear stress stimulates the release of endothelium-dependent dilators, thereby increasing diameter and lowering shear stress. If shear stress is a regulated variable in the coronary microcirculation, the increase in diameter would hypothetically lower shear stress to a normalized value. Inhibition of endothelium-dependent dilators therefore would impair regulation of shear stress and lead to higher levels of intravascular shear during increases in blood flow, ie, shear stress would not be regulated at its baseline value.
The objective of the present study was to test the hypothesis that shear stress is a regulated variable in the canine coronary microcirculation and that this regulation is mediated by nitric oxide (NO). We measured shear stress in coronary microvessels (ranging from arterioles to small arteries) in vivo during basal conditions and maximal coronary blood flow with adenosine and during inhibition of NO synthase under both conditions. Our results indicate that NO regulates microvascular shear stress in the coronary circulation in vivo during elevations in blood flow. We also found that shear stress is effectively regulated, ie, remains constant in small coronary arteries, but not arterioles, during large changes in coronary blood flow.
| Methods |
|---|
|
|
|---|
To visualize the epicardial surface, the heart was exposed by a left thoracotomy at the fifth intercostal space and stabilized in a partial pericardial cradle. A large coronary artery was exposed and a 24-gauge cannula inserted to allow the measurement of coronary artery pressure and the administration of microspheres, intracoronary drugs, and fluorochromes. After an area of easily visible epicardial microvessels was identified, four 22-gauge pins were passed horizontally through the left ventricle to minimize vertical cardiac motion. Neither maneuver appears to compromise coronary tone, because resting blood flow and vasodilator reserve were unaffected in each case.5
Measurement of Coronary Microvascular Diameter
To measure coronary microvascular diameter, the cardiac
surface was illuminated by a stroboscope (Chadwick-Helmuth, 100-W xenon
arc) that was triggered by the maximum LV dP/dt signal to flash once
for 20 to 30 µs at the same point during each cardiac cycle. The
strobe trigger signal was monitored in relation to left
ventricular pressure for a precise determination of the
position of the strobe in the cardiac cycle. The combined use of
low-tidal-volume jet ventilation and brief epicardial illumination,
both synchronized to the cardiac cycle, causes the surface
coronary microvessels to appear virtually motionless when
viewed through an intravital microscope (Leitz Ploemopak, Wild Leitz).
The microscope objectives used were the Leitz EF4 (x4, numerical
aperture 0.22) and the Leitz L10 (x10, numerical aperture 0.22).
To illuminate the inner diameters of the microvessels, 50- to 100-µL aliquots of a 25-mg/mL solution of FITC-dextran in 0.9% saline (MW 500 000) were injected through the coronary cannula. A Leitz H2 excitation-barrier filter was used to activate the fluorescein and receive the emitted light. Each injection causes arterial and venous vessels to fluoresce sequentially for 5 to 10 seconds. The anatomic landmarks of a particular vessel were identified, and 5 to 8 images were obtained over a period of <1 minute with a Cohu silicon-intensified tube video camera (Cohu Intensified CCD Camera). The images were digitized directly from the camera by a frame digitizer (Scion Image, National Institutes of Health) and were transferred to a Macintosh computer (Apple Computer Inc) for diameter measurements with appropriate software (Image 2.18, National Institutes of Health Research Services Branch). Diameters were measured by aligning cursors at the vessel edges, the measurements in pixels being converted to micrometers by use of a conversion factor determined with a micrometer grid. Typically, microvascular measurements over each image acquisition period vary by < ±3% from the average value. Vessels in which the control microvascular diameters after interventions vary from the previous baseline by >10% were excluded from analysis.
Measurement of Coronary Microvascular Velocity
A procedure similar to that designed by Nellis et
al6 was used to measure flow velocities in the epicardial
coronary microcirculation in vivo. The strobe was
triple-flashed during a single video frame (33 ms for 1 complete video
image); thus, 3 images, separated in time (8 ms between flashes), are
captured on the same video frame (Figure 1
). The fluorescent particles
appear 3 times in each image, and the velocity can be calculated as the
quotient of the distance moved by the microspheres and the time
interval between strobe flashes. Fluorescent
microspheres (10 µm, Fluoresbrite YG plain
microspheres, Polyscience, Inc) suspended in a mixture of
dilute fluorescein solution and 0.9% saline were injected
into the coronary artery, and images during a fixed interval of
the cardiac cycle were obtained.
|
Measurement of Coronary Blood Flow
To measure coronary blood flow, a segment of an
epicardial coronary artery proximal to the insertion of the
catheter was dissected free of surrounding adventitia, and a 2.5B
Transonics flow probe was placed around the vessel. The probe was
covered in an ultrasonic conduction jelly, and flow data were monitored
on a Transonics T206 Flowmeter (Transonics Inc) and recorded on a
Macintosh IIcx with LabVIEW 2 Software (National Instruments).
Calculation of Shear Stress
Shear stress was calculated from the measurements of
microvascular flow velocities, blood viscosity, and the radius of the
microvessel from the formula tw=(4v
)/r, where
tw is shear stress, v is microvascular flow
velocity,
is blood viscosity, and r is the radius of the blood
vessel. Viscosity was estimated from an arterial blood
hematocrit and shear rate by use of the relationship described by
Brooks et al.7 According to this relationship, when shear
rates exceed 50 to 100 s-1, variations in the
hematocrit observed in these studies have negligible effects on
viscosity. Because shear rates in this study exceed this level even in
the basal state, we assumed that variations between the systemic and
microvascular hematocrits would have no significant effect on shear
stress calculations.
Experimental Protocols
Shear stress experiments were divided into 4 separate protocols.
In each experiment, the preparation was allowed to stabilize 15 to 30
minutes, and basal diameters of each vessel were obtained. Animals were
then introduced into 1 of the following protocols.
Basal Shear Stress
After stabilization and diameter acquisition, velocity
measurements were obtained.
Shear Stress During Maximal Vasodilation
Adenosine 25 µg ·
kg-1 · min-1 was
infused into the coronary artery for 10 minutes. Microvascular
diameters and velocities were obtained during adenosine
administration.
Basal Shear Stress After Inhibition of NO
NG-Monomethyl-L-arginine
(L-NMMA, 300 µg · kg-1 ·
min-1) was infused into the coronary
artery for 20 minutes. Microvascular diameters and velocities were
obtained after L-NMMA administration.
Shear Stress During Maximal Vasodilation After Inhibition of
NO
L-NMMA was infused into the coronary artery for 20
minutes. Adenosine was then infused into the coronary
artery for 10 minutes. Microvascular diameters and velocities were
obtained during adenosine administration after L-NMMA.
Regulation of Shear Stress
The goal of this study was to determine the degree to which
shear stress is regulated. In an unregulated system, such as a rigid
tube, shear stress would increase proportionately to flow velocity.
Therefore, a hypothetical unregulated shear stress would be basal shear
stress increasing proportionately to velocity, ie, if adenosine
doubled microvascular velocity, then the unregulated shear stress would
also be doubled. The difference between the experimental measurement
and the calculated unregulated value was the estimated regulation of
shear stress. To calculate shear stress (SS) regulation, the following
equation was used: SS regulation=(observed ADO SS-observed basal
SS)/(unregulated high-flow SS-observed basal SS). If the observed
shear stress during vasodilation were equal to the unregulated, shear
stress regulation would be zero. If shear stress with adenosine
were unchanged from basal, shear stress regulation would be 1, or
perfect regulation. To account for the possible
heterogeneity of shear stress regulation in the
coronary circulation, we calculated shear stress regulation in
small arteries (>160 µm in diameter) and arterioles (<160
µm).
Drugs
All drugs were dissolved in 0.9% saline solution.
Propranolol, adenosine, and buffer components were
purchased from Sigma Chemical Co. L-NMMA was purchased from
RBI.
Statistics
All statistical analyses were performed on StatView
software for the Macintosh (Abacus Concepts). Differences in shear
stress, vascular diameter, and microvascular velocity were evaluated by
ANOVA with Fisher's protected least significant difference as the post
hoc multiple comparison test. Regression lines were obtained by
best-fit algorithms using StatView. Data are presented as
mean±SEM. Significance was accepted at P<0.05 in all
experiments.
| Results |
|---|
|
|
|---|
We also optimized the individual interventions used in these studies, specifically, the effects of adenosine and L-NMMA on total coronary blood flow. Basal coronary blood flow was 12±3 mL/min (n=4), and intracoronary infusion of adenosine (25 µg · kg-1 · min-1) increased coronary blood flow 5.3-fold to 62±10 mL/min. The blood concentration of adenosine was estimated at 16 µmol/L (infusion concentrationxinfusion rate/coronary blood flow), which is far in excess of the EDmax of 4 to 5 µmol/L reported previously.8 We are therefore confident that the intervention described produced maximal coronary vasodilation.
L-NMMA was used to inhibit NO at a dose that impaired both
acetylcholine-mediated dilation (fluorescence microangiography)
and increase in blood flow by >60%. L-NMMA (100 µg ·
kg-1 · min-1 or
300 µmol/L) had no effect on either resting (12±3
[control] versus 12±3 [L-NMMA] mL/min) or vasodilated
(adenosine) (62±9 [control] versus 63±9 [L-NMMA] mL/min)
coronary blood flow. Intracoronary infusion of
adenosine or L-NMMA did not produce significant changes in
aortic blood pressure or heart rate.
Finally, we determined the number of 10-µm microspheres that
could be infused without perturbing coronary vascular
hemodynamics. These experiments determined that
4x106 spheres could be infused without effect
on basal or maximal (adenosine-induced) coronary blood
flow (±10%), heart rate, or aortic pressure. On the basis of these
studies, no more than 4x106 microspheres
were infused into the coronary artery.
Microvascular Velocity and Shear Stress: Basal Conditions
The relationship between microvascular diameter and velocity is
shown in Figure 2A
. Velocity averaged
7±1 mm/s. The relationship between shear stress and diameter is
shown in Figure 2B
. Shear stress was heterogeneously
distributed, with arterioles (<160 µm) showing significantly
higher shear stress than small arteries (>160 µm) (19±2
[arterioles] versus 10±2 [small arteries]
dyn/cm2, P<0.005). The correlation
between shear stress and diameter was best described by a second-order
polynomial equation (P<0.05).
|
Microvascular Velocity and Shear Stress Measurements: Maximal
Coronary Vasodilation
The effect of maximal vasodilation caused by adenosine on
the relationship between diameter and velocity is shown in Figure 3A
. Microvascular velocity during
adenosine infusion increased 114% to 15±1 mm/s from
baseline conditions (7±1 mm/s, P=0.0001). The effect
of adenosine on shear stress is shown in Figure 3B
. The
relationship between shear stress and microvascular diameter was best
fit by a second-order polynomial equation (P<0.05). During
vasodilation, shear stress was markedly increased in coronary
arterioles (37±5 dyn/cm2) compared with basal
values (19±2 dyn/cm2, P<0.05). In
small arteries, shear stress was only modestly increased during
elevated coronary blood flow, to 13±3
dyn/cm2, a value not significantly different from
basal shear stress in these vessels.
|
Microvascular Velocity and Shear Stress Measurements During
Inhibition of NO Synthase
The effect of NO synthase inhibition by L-NMMA on the relationship
between diameter and velocity is shown in Figure 4A
. Microvascular velocity after L-NMMA
was not statistically different from control (7±1 [basal] versus
10±1 [L-NMMA] mm/s, P=0.06). The effect of L-NMMA on
shear stress is shown in Figure 4B
. Shear stress was also not
significantly altered by L-NMMA in either small arterioles (19±2
[basal] versus 25±6 [L-NMMA] dyn/cm2) or
small arteries (10±1 [basal] versus 10±2 [L-NMMA]
dyn/cm2). The relationship between shear stress
and microvascular diameter was best fit by a second-order polynomial
equation (P=0.001).
|
The effect of L-NMMA during near-maximal coronary vasodilation
on the relationship between diameter and velocity is shown in Figure 5A
. Microvascular velocity during
adenosine infusion (21±1 mm/s) was higher on average by
133% than L-NMMA alone (10±1 mm/s, P<0.001) and 50%
greater than adenosine without NO synthase blockade (15±1
mm/s, P<0.01). The effect of adenosine on shear
stress is shown in Figure 5B
. In arterioles, shear stress during
adenosine dilation after L-NMMA was 54±5 mm/s,
significantly greater than with L-NMMA alone (25±6 mm/s,
P<0.001). Shear stress was also 45% greater than with
adenosine alone (37±5 [L-NMMA] versus 54±5
[L-NMMA+adenosine] dyn/cm2,
P<0.05). In small arteries, shear stress was on average
280% greater than with L-NMMA alone (10±2 [L-NMMA] versus 28±4
[L-NMMA+adenosine] dyn/cm2,
P<0.01) and 115% greater than with adenosine alone
(13±3 [L-NMMA] versus 28±4 [L-NMMA+adenosine]
dyn/cm2, P<0.01). The relationship
between shear stress and microvascular diameter is best described by a
second-order polynomial equation (P<0.001).
|
Regulation of Shear Stress
The degree of shear stress regulation across the coronary
microcirculation is shown in Figure 6
.
Shear stress regulation was analyzed in small arteries
(>160 µm) and arterioles (<160 µm). Small arteries
demonstrated pronounced shear stress regulation, with shear stress
increased only 30% in response to a 114% increase in velocity.
Arterioles demonstrated negligible shear stress regulation, increasing
shear stress by 94% when velocity increased by 114%. After L-NMMA,
shear stress regulation in small arteries was virtually abolished, with
shear stress increasing parallel to velocity. Shear stress regulation
in arterioles was unaffected by L-NMMA.
|
| Discussion |
|---|
|
|
|---|
Critique of the Methodology
The experiments for measuring microvascular velocity have a number
of caveats. First, only the epicardial circulation was visualized in
these experiments. As has been discussed previously, the epicardial
circulation may have features different from those of the endocardial
circulation, although such differences are distinguished largely by
magnitude rather than direction.9 A second concern would
be that the velocity measurements of spheres moving too close to the
vessel wall would be compounded by adhesion of the sphere to the cells
lining the vessel instead of being purely a function of blood flow. To
account for this, spheres moving within 5% of the diameter margin were
excluded from analysis, and to eliminate the possibility of an
artifact from spheres moving close to the upper and lower surfaces of
the vessel lumen, we measured only spheres in sharp focus. Because the
focal plane was in the lumen, spheres moving above or below this plane
were not in sharp focus and were excluded. Finally, the principal
artifact affecting the determination of microvascular velocity is the
motion of the tissue itself. Tissue motion was determined by
measurement of the motion of spheres already embolized into the
coronary microcirculation. Two exclusion criteria were used to
limit the impact of tissue motion on the velocity determinations. The
first was to limit the range of acceptable tissue motion to 25% of the
velocity measured. For example, if the sphere moved 100 µm in a
given frame, tissue motion (as determined from lodged spheres) was
excluded if it exceeded 25 µm in that frame. The second
criterion was to limit the acceptable direction of tissue motion. In
preliminary analysis, it was determined that tissue motion
perpendicular to the direction of velocity produced only minor effects
on velocity measurements. It was judged to be too difficult to account
for the effect of tissue motion on the velocity of spheres moving
parallel to the direction of tissue motion. Therefore, only vessels
running perpendicular (within an angle of
15%) to the tissue motion
were accepted for analysis. Attesting to the fidelity of our
measurements, similar values of basal coronary flow velocity
have been reported by others.6 10
Shear Stress in the Coronary Microcirculation
We have made several observations regarding shear stress in the
coronary microvasculature in vivo. First, shear stress is
heterogeneously distributed; arterioles <160 µm
have increased levels of shear stress relative to small
coronary arteries. Second, the levels of shear stress
present in the microvasculature at rest are greater than has been
reported to cause maximal arteriolar dilation in vitro. Finally, our
evidence suggests that shear stress is at least partially regulated in
the coronary microvasculature.
The observation that shear stress is elevated in microvascular vessels has been reported previously in other vascular beds. In 1978, Lipowsky and coworkers11 reported arteriolar shear stresses in the mesenteric bed averaging 47 dyn/cm2 in vessels <100 µm in diameter. A similar range of velocity-diameter relationship in the cat mesentery and the rabbit omentum was reported earlier,12 and although shear stress was not calculated, it was probably similar to values reported in the Lipowsky study. In the present study, shear stress ranged 15 to 23 dyn/cm2 at rest in vessels ranging from 100 to 150 µm in diameter. Although the range of diameters measured is not perfectly overlapping with previous reports, the relationship between shear stress and diameter described by our data predicts a similar range of shear stress values in arterioles of the caliber of those in these previous studies. This observation suggests that the relationship between diameter and shear stress may be similar across different vascular beds.
The high levels of shear stress observed in these studies present a
puzzle about the vasoactive sensitivity of these vessels in vitro. Kuo
et al2 reported that values of shear stress at 2 to 4
dyn/cm2 produced maximal vasodilation in isolated
coronary arterioles. This value is
10% of the values
obtained in these in vivo studies. One explanation that accounts for
both results could be the presence of blood in vivo. Because hemoglobin
scavenges NO,13 it may cause a rightward shift in the
relationship between NO and shear stress. Studies of isolated vessels
perfused with blood are needed to address the role of interactions with
hemoglobin and other blood products in modulating vascular
responses to shear stress.
To determine whether shear stress was a regulated variable in the coronary microcirculation, we increased coronary flow velocity maximally with adenosine. We selected adenosine because it acts primarily at the level of the distal microvasculature.14 This allowed examination of downstream dilation of vessels without the confounding effects of direct dilation. If shear stress were a regulated variable in coronary microvessels (100 to 300 µm in diameter), it would remain constant as flow velocity increased. Alternatively, a proportionate increase in shear stress parallel to the increase in flow would argue against any regulation. We observed heterogeneous control of shear stress in coronary microvessels of different sizes during adenosine-induced vasodilation. In small coronary arteries (>160 µm), there was a pronounced degree of regulation; shear stress increased only 30% relative to a 114% increase in velocity (73% regulation). In contrast, arterioles showed poor regulation; shear stress increased 94% to a 114% increase in velocity (17% regulation). Taken together, these observations suggest that regulation of shear stress is heterogeneous in the coronary circulation and is more important in small coronary arteries than downstream arterioles.
Effect of NO Synthase Inhibition on Microvascular Shear
Stress
To determine whether the observed modulation of shear stress was
mediated by NO, L-NMMA was infused into the coronary
circulation to antagonize NO synthase. Several observations were made.
First, L-NMMA had no effect on either basal diameter or shear stress.
Second, shear stress was considerably increased during
adenosine infusions after L-NMMA relative to adenosine
alone.
The effects of NO inhibition on resting hemodynamics are controversial. Some studies report reductions in blood flow or diameter in some preparations13 15 but no effect in others.16 17 18 This variation may be accounted for by variations in dose, duration, and agent used. In the present experiments, we observed no effect of L-NMMA on resting diameter or shear stress. There are 2 potential caveats to this observation. The first is that we inhibited NO alone. Jones et al15 have observed microvascular constriction of small coronary arteries during administration of NG-nitro-L-arginine methyl ester in conjunction with indomethacin. Previous studies have suggested a role for prostanoids in the response to changing shear.4 13 Because we observed no effect using a preparation very similar to that of Jones et al, we conclude that interactions between NO and prostanoids may account for the disparate results. The second important aspect is that these studies are performed in the coronary circulation, as opposed to the systemic circulation. Koller et al19 20 have observed pronounced effects of NO inhibition at rest in the cremaster preparation. Because the skeletal and other systemic circulations are under high basal tone at rest, it is possible that their sensitivity to shear might be greater than the coronary circulation, in which flow is relatively quite high. Finally, it should be stated that the effect of NO inhibition on resting coronary blood flow that could produce the 10% to 20% decrease reported in some studies might be due to very small changes in diameter, especially if those changes are distributed throughout various sizes of coronary arteries. Such changes may be beyond the resolution of our measurements. We therefore must exercise caution in any conclusion that NO does not modulate basal shear stress. However, we can maintain that the basal role of NO is small in the coronary microcirculation.
In contrast to the basal state, shear stress increased dramatically after NO inhibition when blood flow was elevated. In small coronary arteries, in which shear stress is normally well regulated, NO inhibition virtually abolished this regulation, ie, shear stress increased proportionally to velocity. In arterioles, shear stress was poorly regulated and showed little response to L-NMMA. We are compelled to mention the possibility that in vivo, coronary arterioles may regulate shear stress but at lower flow rates than produced by maximal dilation. However, we can state with conviction that small coronary arteries regulate shear stress much more effectively than coronary arterioles. Taken together, these observations demonstrate that in small coronary arteries, in which shear stress is well regulated during large changes in coronary blood flow, NO plays a central role in that control.
In conclusion, these studies provide new observations on the regulation of shear stress in the coronary microvasculature. In addition to the first estimation of coronary microvascular shear stress in vivo, we observed active regulation of this variable in the small coronary arteries by NO. We conclude that NO plays an important role at specific sites in the coronary circulation in regulating shear stress.
| Acknowledgments |
|---|
Received February 26, 1999; revision received May 24, 1999; accepted June 2, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Chambers and S. Mitragotri Long Circulating Nanoparticles via Adhesion on Red Blood Cells: Mechanism and Extended Circulation Experimental Biology and Medicine, July 1, 2007; 232(7): 958 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Rogers, T. Kiyooka, and W. M. Chilian Is there a need for another model on the pulsatile nature of coronary blood flow? Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1034 - H1035. [Full Text] [PDF] |
||||
![]() |
E. Mairey, A. Genovesio, E. Donnadieu, C. Bernard, F. Jaubert, E. Pinard, J. Seylaz, J.-C. Olivo-Marin, X. Nassif, and G. Dumenil Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood-brain barrier J. Exp. Med., August 7, 2006; 203(8): 1939 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pistea, E. N. T. P. Bakker, J. A. E. Spaan, and E. VanBavel Flow inhibits inward remodeling in cannulated porcine small coronary arteries Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2632 - H2640. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Jensen and C. Agnisola Perfusion of the isolated trout heart coronary circulation with red blood cells: effects of oxygen supply and nitrite on coronary flow and myocardial oxygen consumption J. Exp. Biol., October 1, 2005; 208(19): 3665 - 3674. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Neishi, S. Mochizuki, T. Miyasaka, T. Kawamoto, T. Kume, R. Sukmawan, M. Tsukiji, Y. Ogasawara, F. Kajiya, T. Akasaka, et al. Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration PNAS, August 9, 2005; 102(32): 11456 - 11461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Tune, M. W. Gorman, and E. O. Feigl Matching coronary blood flow to myocardial oxygen consumption J Appl Physiol, July 1, 2004; 97(1): 404 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishikawa, D. W. Stepp, D. Merkus, D. Jones, and W. M. Chilian In vivo role of heme oxygenase in ischemic coronary vasodilation Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2296 - H2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Sorop, J. A.E. Spaan, T. E. Sweeney, and E. VanBavel Effect of Steady Versus Oscillating Flow on Porcine Coronary Arterioles: Involvement of NO and Superoxide Anion Circ. Res., June 27, 2003; 92(12): 1344 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okajima, M. Takamura, P. Vequaud, R. Parent, and M. Lavallee beta -Adrenergic receptor blockade impairs NO-dependent dilation of large coronary arteries during exercise Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H501 - H510. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Tune, K. N. Richmond, M. W. Gorman, and E. O. Feigl Control of Coronary Blood Flow during Exercise Experimental Biology and Medicine, April 1, 2002; 227(4): 238 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huang, D. Sun, E. G. Shesely, E. M. Levee, A. Koller, and G. Kaley Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H429 - H436. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Joyce, T. M. Phernetton, C. E. Shaw, M. L. Modrick, and R. R. Magness Endothelial vasodilator production by uterine and systemic arteries. IX. eNOS gradients in cycling and pregnant ewes Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H342 - H348. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Silber, D. A. Bluemke, P. Ouyang, Y. P. Du, W. S. Post, and J. A. C. Lima The relationship between vascular wall shear stress and flow-mediated dilation: endothelial function assessed by phase-contrast magnetic resonance angiography J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1859 - 1865. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nakamura, K. Egashira, K. Arimura, Y. Machida, T. Ide, H. Tsutsui, H. Shimokawa, and A. Takeshita Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2619 - H2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Stepp, D. Merkus, Y. Nishikawa, and W. M. Chilian Nitric oxide limits coronary vasoconstriction by a shear stress-dependent mechanism Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H796 - H803. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Paniagua, M. B. Bryant, and J. A. Panza Role of Endothelial Nitric Oxide in Shear Stress-Induced Vasodilation of Human Microvasculature : Diminished Activity in Hypertensive and Hypercholesterolemic Patients Circulation, April 3, 2001; 103(13): 1752 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sambuceti, A. L'Abbate, and M. Marzilli Why should we study the coronary microcirculation? Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2581 - H2584. [Full Text] [PDF] |
||||
![]() |
S. Mohlenkamp, L. O. Lerman, A. Lerman, T. R. Behrenbeck, Z. S. Katusic, P. F. Sheedy II, and E. L. Ritman Minimally Invasive Evaluation of Coronary Microvascular Function by Electron Beam Computed Tomography Circulation, November 7, 2000; 102(19): 2411 - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. G. Romanenko, P. F. Davies, and I. Levitan Dual effect of fluid shear stress on volume-regulated anion current in bovine aortic endothelial cells Am J Physiol Cell Physiol, April 1, 2002; 282(4): C708 - C718. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. M. Cornelissen, J. Dankelman, E. VanBavel, and J. A. E. Spaan Balance between myogenic, flow-dependent, and metabolic flow control in coronary arterial tree: a model study Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2224 - H2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Stepp and J. C. Frisbee Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H816 - H820. [Abstract] [Full Text] [PDF] |